Assignee
VELOXIS PHARMACEUTICALS AS
DK18 patents
Top patents by PatentIndex Score
US9161907B2Oct 20, 2015
Modified release compositions comprising tacrolimus
VELOXIS PHARMACEUTICALS AS6 citations92
US8889185B2Nov 18, 2014
Modified release compositions comprising tacrolimus
VELOXIS PHARMACEUTICALS AS11 citations92
US8889186B2Nov 18, 2014
Modified release compositions comprising tacrolimus
VELOXIS PHARMACEUTICALS AS17 citations92
US10548880B2Feb 4, 2020
Solid dispersions comprising tacrolimus
VELOXIS PHARMACEUTICALS AS4 citations84
US9763920B2Sep 19, 2017
Solid dispersions comprising tacrolimus
VELOXIS PHARMACEUTICALS AS3 citations84
US11110081B2Sep 7, 2021
Tacrolimus for improved treatment of transplant patients
VELOXIS PHARMACEUTICALS AS4 citations83
US9775834B2Oct 3, 2017
Regimen for supressing organ rejection
VELOXIS PHARMACEUTICALS AS4 citations82
US9168246B2Oct 27, 2015
Regimen for suppressing organ rejection
VELOXIS PHARMACEUTICALS AS5 citations82
US11129815B2Sep 28, 2021
Solid dispersions comprising tacrolimus
VELOXIS PHARMACEUTICALS AS0 citations73
US11077096B2Aug 3, 2021
Modified release compositions comprising tacrolimus
VELOXIS PHARMACEUTICALS AS0 citations73
US11123331B2Sep 21, 2021
Tacrolimus for improved treatment of transplant patients
VELOXIS PHARMACEUTICALS AS2 citations72
US10864199B2Dec 15, 2020
Tacrolimus for improved treatment of transplant patients
VELOXIS PHARMACEUTICALS AS2 citations72
US11141408B2Oct 12, 2021
Regimen for suppressing organ rejection
VELOXIS PHARMACEUTICALS AS2 citations71
US10485793B2Nov 26, 2019
Regimen for suppressing organ rejection
VELOXIS PHARMACEUTICALS AS2 citations71
US10166190B2Jan 1, 2019
Stabilized tacrolimus composition
VELOXIS PHARMACEUTICALS AS1 citations71
US9757362B2Sep 12, 2017
Modified release compositions comprising tacrolimus
VELOXIS PHARMACEUTICALS AS1 citations62
US11419823B2Aug 23, 2022
Stabilized tacrolimus composition
VELOXIS PHARMACEUTICALS AS0 citations61
US9295653B2Mar 29, 2016
Controlled agglomeration
VELOXIS PHARMACEUTICALS AS0 citations40